Avantor 경영진
경영진 기준 점검 3/4
Avantor CEO는 Emmanuel Ligner, Aug2025 에 임명되었습니다 의 임기는 1년 미만입니다. 총 연간 보상은 $5.90M, 6.4% 급여 및 93.6% 보너스(회사 주식 및 옵션 포함)로 구성됩니다. 는 $696.73K 가치에 해당하는 회사 주식의 0.013% 직접 소유합니다. 경영진과 이사회의 평균 재임 기간은 2.7 년과 4.6 년입니다.
핵심 정보
Emmanuel Ligner
최고경영자
US$5.9m
총 보수
| CEO 급여 비율 | 6.43% |
| CEO 재임 기간 | less than a year |
| CEO 지분 보유율 | 0.01% |
| 경영진 평균 재임 기간 | 2.7yrs |
| 이사회 평균 재임 기간 | 4.6yrs |
최근 경영진 업데이트
Recent updates
AVTR: Reset Expectations And Execution Progress May Support Future Upside
Avantor's updated analyst price target moves lower by several dollars to reflect a reset in fair value to $9.92, as analysts reference reduced price targets across the Street and ongoing questions around market share trends and management execution. Analyst Commentary Recent Street research around Avantor clusters around lower price targets and a downgrade in rating, with most comments focused on valuation reset, market share questions, and confidence in management execution.Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible
Apr 30
AVTR: Expanded Quality Control Capabilities Will Support Execution Turnaround And Future Share Repricing
Analysts have trimmed their average price targets on Avantor, and the updated fair value estimate now stands at about $16.47. This reflects a softer sentiment around the stock as research notes point to share losses, reduced investment, and questions about management's ability to stabilize the business.AVTR: Reset Expectations And Share Repurchases May Support Future Upside
The analyst price target for Avantor has shifted lower to reflect a series of Street target cuts, including a move to $8.50. This change stems from concerns about share losses, constrained investment, and uncertainty over whether management can stabilize the business.AVTR: Execution Turnaround In Core Franchise Will Drive Future Share Repricing
Analysts have lowered their price targets on Avantor, with the updated fair value estimate moving from about $17.68 to $16.13 as they factor in concerns about share losses, underinvestment, and uncertainty around management's ability to stabilize the business, along with a higher assumed discount rate and P/E multiple. Analyst Commentary Recent Street research has tilted cautious on Avantor, highlighted by a downgrade to Underweight with a US$8.50 price target and several cuts to prior price targets.AVTR: Reset Expectations And Buybacks Will Support Future Upside Potential
Analysts have cut their average price target on Avantor by a few dollars to reflect lower fair value estimates, softer assumed revenue growth and profit margins, and a higher future P/E multiple in light of recent broad target reductions from firms across the Street. Several have moved targets in a $2 to $4 range, and one reset its view from $14 to $12.The Market Doesn't Like What It Sees From Avantor, Inc.'s (NYSE:AVTR) Revenues Yet As Shares Tumble 27%
Feb 13
AVTR: Service Expansion And Execution Will Drive Upside From Reset Expectations
Narrative Update: Avantor Analyst Price Target Shift Analysts recently trimmed their price target on Avantor to $12 from $14. This reflects updated views on the life science tools sector and a Q4 outlook where many companies have already set softer expectations for 2026.AVTR: Share Repurchases And Execution Risks Will Shape Turnaround Visibility
Analysts have trimmed their price target on Avantor by about $0.60, reflecting more cautious assumptions on revenue growth and future P/E. This is partly offset by slightly higher profit margin expectations and a marginally lower discount rate.AVTR: Execution Turnaround And Review Process Will Unlock Share Repricing Potential
Avantor's analyst price targets and fair value estimates have inched higher to around $17.68 per share. At the same time, lower assumed revenue growth, a higher discount rate, a reduced future P/E, and sharply higher profit margin expectations reflect analysts' mixed views following recent downgrades and concerns about execution and visibility.AVTR: Share Repurchases Will Drive Upside As Turnaround Visibility Improves
Analysts have modestly lowered their price targets on Avantor by a few dollars per share, generally to the low to mid teens in dollar terms. They cite reduced guidance, weaker quarters and limited visibility around the company’s turnaround and strategic review.AVTR: Share Repurchase Initiative And Execution Will Shape Recovery Prospects Ahead
Analysts have lowered their price target for Avantor from $14 to $12 per share, citing a weak quarter, reduced guidance, and ongoing execution risks as primary concerns behind the updated outlook. Analyst Commentary Bullish Takeaways Bullish analysts have raised price targets ahead of quarterly results, reflecting improved confidence in Avantor’s long-term positioning despite current volatility.AVTR: Share Repurchase And Execution Will Define Turnaround Prospects In 2025
Avantor’s analyst price target has decreased from $13.80 to $13.64. Analysts cite reduced company guidance, execution risks, and ongoing uncertainty surrounding its earnings outlook as key factors driving the revision.Avantor, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
Nov 01AVTR: Activist Pressure And Business Overhaul Will Drive Share Recovery
Avantor’s analyst price target has been reduced from $14.40 to $13.80 per share, as analysts cite ongoing operational headwinds and limited near-term earnings visibility following recent downgrades and mixed guidance. Analyst Commentary Recent analyst notes on Avantor capture a divided outlook, reflecting both positive updates from some firms and notable caution from others as the company contends with ongoing operational challenges.There's No Escaping Avantor, Inc.'s (NYSE:AVTR) Muted Earnings Despite A 28% Share Price Rise
Oct 28Pharma Contracts And R&D Will Drive Growth Amid Price Pressures
Analysts have modestly increased their price target for Avantor, raising it by $0.28 to $14.40. They cite revised expectations for end market recovery and alignment with company outlooks.We Think Avantor (NYSE:AVTR) Is Taking Some Risk With Its Debt
Sep 12Concerns Surrounding Avantor's (NYSE:AVTR) Performance
Aug 12What Is Avantor, Inc.'s (NYSE:AVTR) Share Price Doing?
Jun 26Earnings Working Against Avantor, Inc.'s (NYSE:AVTR) Share Price
May 14Avantor: A Healthier Diagnosis As Expectations Cool
Apr 26Avantor: Mundane Business, Solid Cash Flow, Potential New Risks
Mar 07Avantor: Durable FCF Generator Trading For Cheap
Dec 18Avantor: Uninspiring, Even Amidst Some Green Shoots
Oct 24
New Operating Model And Bioprocessing Innovations Promise Robust Growth And Market Leadership
Implementation of a new operating model and ongoing cost transformation initiatives are streamlining execution and improving net margins through cost savings.Avantor: Yet To Evidence Economic Value For Valuation Repricing, Reiterate Hold
Aug 13CEO 보수 분석
| 날짜 | 총 보수 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | -US$551m |
| Dec 31 2025 | US$6m | US$379k | -US$530m |
보상 대 시장: Emmanuel의 총 보수(USD5.90M)는 US 시장에서 비슷한 규모 기업의 평균(USD8.73M)보다 낮습니다.
보상과 수익: Emmanuel의 보상을 회사 실적과 비교하기에 데이터가 부족합니다.
CEO
Emmanuel Ligner (54 yo)
less than a year
재임 기간
US$5,895,624
보수
Mr. Emmanuel Ligner is President and Chief Executive Officer of Avantor, Inc. from August 18, 2025 and serves as its Director. He was Chief Executive Officer of Cerba HealthCare S.A.S. from March 01, 2024...
리더십 팀
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| President | less than a year | US$5.90m | 0.013% $ 696.7k | |
| Executive VP & CFO | 2.8yrs | US$6.54m | 0.0059% $ 317.9k | |
| Executive VP | 2.8yrs | US$3.75m | 0.0033% $ 181.0k | |
| President of Laboratory Solutions | 1.9yrs | US$5.99m | 0.0024% $ 127.7k | |
| Executive Vice President of Bioscience Production | 2.6yrs | US$5.23m | 0.0036% $ 197.8k | |
| Executive VP & COO | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior VP | 7yrs | 데이터 없음 | 0.019% $ 1.0m | |
| Executive VP & Chief Information Officer | 8.1yrs | US$3.19m | 데이터 없음 | |
| Vice President of Investor Relations | less than a year | 데이터 없음 | 데이터 없음 | |
| Executive VP & Chief Human Resources Officer | 2.8yrs | 데이터 없음 | 0.036% $ 2.0m | |
| Executive Vice President of AMEA | 8.1yrs | 데이터 없음 | 0.0088% $ 476.6k | |
| EVP of Bioscience & Medtech Products and Chief Transformation Officer | no data | 데이터 없음 | 데이터 없음 |
2.7yrs
평균 재임 기간
55yo
평균 나이
경험이 풍부한 관리: AVTR의 경영진은 경험이 있음으로 간주됩니다(평균 재임 2.7 년).
이사회 구성원
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| President | no data | US$5.90m | 0.013% $ 696.7k | |
| Independent Chairman of the Board | 6yrs | US$329.99k | 0.062% $ 3.4m | |
| Independent Director | 4.5yrs | US$329.99k | 0.0051% $ 278.8k | |
| Chair of Scientific Advisory Board | 2.7yrs | US$3.09m | 데이터 없음 | |
| Independent Director | 6.7yrs | US$317.49k | 0.0071% $ 385.3k | |
| Independent Director | 6.1yrs | US$324.99k | 0.0064% $ 345.6k | |
| Independent Director | 5yrs | US$314.99k | 0.0044% $ 240.8k | |
| Member of Scientific Advisory Board | 2.7yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 4.6yrs | US$317.49k | 0.0040% $ 215.8k | |
| Independent Director | 4.8yrs | US$312.49k | 0.0042% $ 228.8k | |
| Member of Scientific Advisory Board | 2.7yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 2.7yrs | 데이터 없음 | 데이터 없음 |
4.6yrs
평균 재임 기간
59yo
평균 나이
경험이 풍부한 이사회: AVTR의 이사회는 경험이 있음으로 간주됩니다(평균 재임 4.6 년).
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/04 21:19 |
| 종가 | 2026/05/01 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Avantor, Inc.는 29명의 분석가가 다루고 있습니다. 이 중 14명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Catherine Ramsey Schulte | Baird |
| Luke Sergott | Barclays |
| Michael Ryskin | BofA Global Research |